Detalhe da pesquisa
1.
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
N Engl J Med
; 375(11): 1019-32, 2016 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27626517
2.
Tracing teachers' perceptions of entanglement of digitally-mediated educational activities and learning environments: a practice-oriented method.
Learn Environ Res
; 26(2): 469-489, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36467115
3.
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study.
J Pediatric Infect Dis Soc
; 9(2): 194-201, 2020 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30849175
4.
Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older.
J Gerontol A Biol Sci Med Sci
; 74(8): 1231-1238, 2019 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29955836
5.
Immunogenicity and safety of primary and booster vaccination with 2 investigational formulations of diphtheria, tetanus and Haemophilus influenzae type b antigens in a hexavalent DTPa-HBV-IPV/Hib combination vaccine in comparison with the licensed Infanrix hexa.
Hum Vaccin Immunother
; 13(7): 1505-1515, 2017 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28340322
6.
A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine.
Pediatr Infect Dis J
; 25(7): 590-5, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16804427
7.
Safety and immunogenicity of an intramuscular quadrivalent influenza vaccine in children 3 to 8 y of age: A phase III randomized controlled study.
Hum Vaccin Immunother
; 12(12): 3072-3078, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27565435
8.
Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.
Pediatr Infect Dis J
; 34(7): 774-82, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069949
9.
Immunogenicity of 10-valent pneumococcal nontypeable Haemophilus Influenzae Protein D Conjugate Vaccine when administered as catch-up vaccination to children 7 months to 5 years of age.
Pediatr Infect Dis J
; 30(8): e130-41, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21540760
10.
Safety and immunogenicity of a booster dose of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine coadministered with measles-mumps-rubella-varicella vaccine in children aged 12 to 16 months.
Pediatr Infect Dis J
; 29(6): e47-56, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20508478
11.
RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.
Vaccine
; 28(2): 345-51, 2009 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-19879226